SlideShare a Scribd company logo
EFFECTS AND
MANAGEMENT
OF COVID 19
ON
PREGNANCY PRESENTED BY
MISS DAMINEE
PATEL
CONTENT
INTRODUCTION OF COVID – 19
EFFECT OF COVID -19 ON
PREGNANCY
MANAGEMENT OF COVID 19 ON
PREGNANCY
INTRODUCTION OF COVID 19
AGENT – Novel
corona virus called
covid 19 caused by
SARS COV- 2
INCUBATION
RANGE- 2.2 to
11.5 days
Mode of infection
• Droplet
• Contact
• Fomites
Age group
Any of age group
Above 30 year
Less common in
below 10 year
EFFECTS IN NON PREGNANT STATE
Cough
URT infection
Fever
Muscle pain
Myalgia
Headache
Shortness of breath
Loss of smell and taste
Nausea vomiting and diarrhea
Confirmatory test
RT PCR
It is a RNA virus and specific gene is
RdRp gene.
EFFECTS OF COVID -19 ON
PREGNENCY
Several research findings suggest that
pregnant women at suspect or confirmed
covid 19 they are more likely to need ICU
as compared to non -pregnant women.
EFFECT ON PREGNANCY
The findings of many study supported that pregnant
women are not greater risk of severe illness than
non- pregnant women.
Prone to infection
Higher risk for hospitalization , ICU and
ventilators.
Continued….
Perinatal anxiety
Depression
Sometime Domestic violence
More chance to occur pneumonia
Pregnant women with heart
disease are at highest risk
(congenital or acquired).
EFFECTS ON LABOUR
Preterm labor.
Intra uterine growth retardation
Chances of infection
Low birth weight baby
Increase risk of transmission.
EFFECT ON FETUS
Early pregnancy - miscarriage
Late pregnancy – Loss of fetus, and preterm
labor.
There is no evidence currently that the virus is
teratogenicity. Long term data is awaited.
COVID-19 infection is currently not an
indication for Medical Termination of Pregnancy.
TRANSMISSION
 With regard to vertical transmission (transmission from
mother to baby antenatally or intrapartum), emerging
evidence now suggests that vertical transmission is
probable, although the proportion of pregnancies affected
and the significance to the neonate has yet to be determined.
 At present, there are no recorded cases of vaginal secretions
being tested positive for COVID-19.
 At present, there are no recorded cases of breast milk being
tested positive for COVID-19.
DOs
If a woman meets
criteria for COVID-
19 testing, she
should be tested.
Until test results are
available, she should
be treated as though
she has confirmed
COVID-19.
DONTs
Do not delay
obstetric
management in
order to test for
COVID-19.
DOs
routine growth
scans not for a strict
guidance-based
indication, routine
investigations
should be done
regularly
DONTs
Elective procedures
like induction of
labour for
indications that are
not strictly
necessary,
If ultrasound
equipment is used,
it should be
decontaminated
after use.
Do not expose
unnecessary
SPECIFIC OBSTETRIC
MANAGEMENT
Medical History For all pregnant women obtain the
following information:
 A detailed travel history
 History of exposure to people with symptoms
of COVID-19
 Symptoms of COVID-19
 Coming from hot spot area
 Immuno compromissed conditions.
MANAGEMENT OF COVID-19 IN
PREGNANCY
Women should be advised to attend routine
antenatal care, unless they meet current self-
isolation criteria.
For women who have had symptoms,
appointments can be deferred until 7 days after the
start of symptoms, unless symptoms (aside from
persistent cough) become severe. Fetal Kick count
to be maintained.
Continued…
If needed to visit health center, should take own
transport or call 108, informing the ambulance
staff about her status.
For women who are self-quarantined because
someone in their household has possible symptoms
of COVID-19, appointments should be deferred for
14 days.
Any woman who has a routine appointment
delayed for more than 3 weeks should be
contacted. (In rural areas ANMs/ASHAs can
contact by telephone/ routine household visits with
PPE).
Continued…
Even if a woman has previously tested
negative for COVID-19, if she presents
with symptoms again, COVID-19 should
be suspected.
Referral to antenatal ultrasound services
for foetal growth surveillance is
recommended after 14 days following the
resolution of acute illness.
Continue…
 Ob-gyns and other health care practitioners should
follow the national protocol.
 Health care practitioners should immediately notify
infection control personnel at their health care facility
and their local or state health department for COVID-
19.
 A registry for all women admitted to with confirmed
COVID-19 infection in pregnancy should be
maintained. Maternal and neonatal records including
outcome should be completed in detail and preserved
for analysis in future.
Continue…
 Health care providers should create a plan to address the
possibility of a decreased health care workforce, potential
shortage of personal protective equipment, limited
isolation rooms, and should maximize the use of tele health
across as many aspects of prenatal care as possible.
 Each facility should consider their appropriate space and
staffing needs to prevent transmission of the virus that
causes COVID-19.
 Pregnant women should be advised to increase their social
distancing to reduce the risk of infection and practice hand
hygiene.
Continue…
 Pregnant women should be advised to increase their
social distancing to reduce the risk of infection and
practice hand hygiene.
 Health care practitioners should promptly notify
infection control personnel.
 Intrapartum services should be provided in a way that
is safe, with reference to minimum staffing
requirements and the ability to provide emergency
obstetric, anaesthetic and neonatal care where
indicated.
Continue…
A single, asymptomatic birth partner should be
permitted to stay with the woman, at a minimum,
through pregnancy and birth.
Visitors should be instructed to wear appropriate
PPE, including gown, gloves, face mask, and eye
protection.
continue…
Women should be met at the maternity unit
entrance by staff wearing appropriate PPE and
be provided with a surgical face mask.
The face mask should not be removed until
the woman is isolated in a suitable room.
Staff providing care should take Personal
Protective Equipment (PPE) precautions as
per national guidance.
THANK YOU

More Related Content

What's hot

Hydatidiform Mole
Hydatidiform MoleHydatidiform Mole
Hydatidiform Mole
Sandhya Kumari
 
Covid 19 in Pregnancy
Covid 19 in PregnancyCovid 19 in Pregnancy
Covid 19 in Pregnancy
Basem Hamed
 
Biophysical profile
Biophysical profileBiophysical profile
Biophysical profile
Sandhya Kumari
 
Management of ectopic pregnancy
Management of ectopic pregnancyManagement of ectopic pregnancy
Management of ectopic pregnancy
Medaramitla Sadhana reddy
 
TORCH
TORCHTORCH
Abnormal uterine action
Abnormal uterine actionAbnormal uterine action
Abnormal uterine action
Priyanka Gohil
 
ANTENATAL CARE
ANTENATAL CARE ANTENATAL CARE
ANTENATAL CARE
Sachin Gadade
 
Prevention of Mother to Child Transmission of HIV 2017
Prevention of Mother to Child Transmission of HIV 2017Prevention of Mother to Child Transmission of HIV 2017
Prevention of Mother to Child Transmission of HIV 2017
Helen Madamba
 
Cervical Cancer
Cervical CancerCervical Cancer
Cervical Cancer
DJ CrissCross
 
Normal labour
Normal labourNormal labour
Normal labour
raj kumar
 
IUGR
IUGRIUGR
Mechanism of labour
Mechanism of labourMechanism of labour
Vaginal Fistula: Causes, Symptoms, Diagnosis, and Treatment
Vaginal Fistula: Causes, Symptoms, Diagnosis, and TreatmentVaginal Fistula: Causes, Symptoms, Diagnosis, and Treatment
Vaginal Fistula: Causes, Symptoms, Diagnosis, and Treatment
Lazoi Lifecare Private Limited
 
Uterine cancer (Endometrial & Cervical Cancer)
Uterine cancer (Endometrial & Cervical Cancer)Uterine cancer (Endometrial & Cervical Cancer)
Uterine cancer (Endometrial & Cervical Cancer)
FarazaJaved
 
Bartholin gland cyst
Bartholin gland cyst Bartholin gland cyst
Bartholin gland cyst
Sabita Saichandran
 
11.Postpartum+Hemorrhage
11.Postpartum+Hemorrhage11.Postpartum+Hemorrhage
11.Postpartum+Hemorrhage
Deep Deep
 
$ Breast engorgement $
$ Breast engorgement $$ Breast engorgement $
$ Breast engorgement $
Godwin Pangler
 
Physiological changes in puerperium
Physiological changes in puerperiumPhysiological changes in puerperium
Physiological changes in puerperium
Shrooti Shah
 
Maternal morbidity and mortality
Maternal morbidity and mortalityMaternal morbidity and mortality
Maternal morbidity and mortality
Abiya Mary Biju
 
Management of Cervical Incompetence
Management of Cervical IncompetenceManagement of Cervical Incompetence
Management of Cervical Incompetence
Kattey Kattey
 

What's hot (20)

Hydatidiform Mole
Hydatidiform MoleHydatidiform Mole
Hydatidiform Mole
 
Covid 19 in Pregnancy
Covid 19 in PregnancyCovid 19 in Pregnancy
Covid 19 in Pregnancy
 
Biophysical profile
Biophysical profileBiophysical profile
Biophysical profile
 
Management of ectopic pregnancy
Management of ectopic pregnancyManagement of ectopic pregnancy
Management of ectopic pregnancy
 
TORCH
TORCHTORCH
TORCH
 
Abnormal uterine action
Abnormal uterine actionAbnormal uterine action
Abnormal uterine action
 
ANTENATAL CARE
ANTENATAL CARE ANTENATAL CARE
ANTENATAL CARE
 
Prevention of Mother to Child Transmission of HIV 2017
Prevention of Mother to Child Transmission of HIV 2017Prevention of Mother to Child Transmission of HIV 2017
Prevention of Mother to Child Transmission of HIV 2017
 
Cervical Cancer
Cervical CancerCervical Cancer
Cervical Cancer
 
Normal labour
Normal labourNormal labour
Normal labour
 
IUGR
IUGRIUGR
IUGR
 
Mechanism of labour
Mechanism of labourMechanism of labour
Mechanism of labour
 
Vaginal Fistula: Causes, Symptoms, Diagnosis, and Treatment
Vaginal Fistula: Causes, Symptoms, Diagnosis, and TreatmentVaginal Fistula: Causes, Symptoms, Diagnosis, and Treatment
Vaginal Fistula: Causes, Symptoms, Diagnosis, and Treatment
 
Uterine cancer (Endometrial & Cervical Cancer)
Uterine cancer (Endometrial & Cervical Cancer)Uterine cancer (Endometrial & Cervical Cancer)
Uterine cancer (Endometrial & Cervical Cancer)
 
Bartholin gland cyst
Bartholin gland cyst Bartholin gland cyst
Bartholin gland cyst
 
11.Postpartum+Hemorrhage
11.Postpartum+Hemorrhage11.Postpartum+Hemorrhage
11.Postpartum+Hemorrhage
 
$ Breast engorgement $
$ Breast engorgement $$ Breast engorgement $
$ Breast engorgement $
 
Physiological changes in puerperium
Physiological changes in puerperiumPhysiological changes in puerperium
Physiological changes in puerperium
 
Maternal morbidity and mortality
Maternal morbidity and mortalityMaternal morbidity and mortality
Maternal morbidity and mortality
 
Management of Cervical Incompetence
Management of Cervical IncompetenceManagement of Cervical Incompetence
Management of Cervical Incompetence
 

Similar to Management of covid during pregnancy

CARE OF PREGNANT WOMEN WITH AYURVEDA IN COVID19
CARE OF PREGNANT WOMEN WITH AYURVEDA IN COVID19CARE OF PREGNANT WOMEN WITH AYURVEDA IN COVID19
CARE OF PREGNANT WOMEN WITH AYURVEDA IN COVID19
MrityunjoyBaroi1
 
Lecture 9 Coronavirus Infection in Pregnancy
Lecture 9 Coronavirus Infection in PregnancyLecture 9 Coronavirus Infection in Pregnancy
Lecture 9 Coronavirus Infection in Pregnancy
Public Health & Medical Academy
 
CARE OF PREGNANT WOMEN DURING COVID 19 PANDEMIC
CARE OF PREGNANT WOMEN DURING COVID 19 PANDEMICCARE OF PREGNANT WOMEN DURING COVID 19 PANDEMIC
CARE OF PREGNANT WOMEN DURING COVID 19 PANDEMIC
khushboo singh
 
COVID-19 in pregnant and postpartum women.pptx
COVID-19 in pregnant and postpartum women.pptxCOVID-19 in pregnant and postpartum women.pptx
COVID-19 in pregnant and postpartum women.pptx
NkosinathiManana2
 
Corona Virus Infection in Pregnancy by: Prof. Haleema A. Hashmi
Corona Virus Infection in Pregnancy by: Prof. Haleema A. HashmiCorona Virus Infection in Pregnancy by: Prof. Haleema A. Hashmi
Corona Virus Infection in Pregnancy by: Prof. Haleema A. Hashmi
Usman Hingoro
 
Overview of covid 19 during pregnancy and unani medicine
Overview of covid 19 during pregnancy and unani medicineOverview of covid 19 during pregnancy and unani medicine
Overview of covid 19 during pregnancy and unani medicine
Arshiya Sultana
 
ytp newsletter ekika singh.pdf
ytp newsletter ekika singh.pdfytp newsletter ekika singh.pdf
ytp newsletter ekika singh.pdf
NARENDRA C MALHOTRA
 
Restart fertility in Covid19: Indian Perspective and International Guidance
Restart fertility in Covid19: Indian Perspective and International GuidanceRestart fertility in Covid19: Indian Perspective and International Guidance
Restart fertility in Covid19: Indian Perspective and International Guidance
Shivani Sachdev
 
Pregnant Woman with COVID-1.pptx
Pregnant Woman with COVID-1.pptxPregnant Woman with COVID-1.pptx
Pregnant Woman with COVID-1.pptx
shaila55
 
Covid 19 & and pregnancy
Covid 19 & and pregnancyCovid 19 & and pregnancy
Covid 19 & and pregnancy
Mital Patel
 
Neha diwan ppt on covid19 in pregnancy
Neha diwan ppt on covid19 in pregnancyNeha diwan ppt on covid19 in pregnancy
Neha diwan ppt on covid19 in pregnancy
NEHAADIWAN
 
COVID-19 in Pregnancy Annual Perinatal2022 - Copy.pptx
COVID-19 in Pregnancy Annual Perinatal2022 - Copy.pptxCOVID-19 in Pregnancy Annual Perinatal2022 - Copy.pptx
COVID-19 in Pregnancy Annual Perinatal2022 - Copy.pptx
LaFleeceWilliams
 
Corona and pregnancy
Corona and pregnancyCorona and pregnancy
Corona and pregnancy
GIMSR, Visakhapatnam, AP, India
 
Optimizing anc in pregnant women in sars co v-2 times
Optimizing anc in pregnant women in sars co v-2 times Optimizing anc in pregnant women in sars co v-2 times
Optimizing anc in pregnant women in sars co v-2 times
NARENDRA C MALHOTRA
 
Pregnancy and covid 19
Pregnancy and covid 19Pregnancy and covid 19
Pregnancy and covid 19
Shazia Iqbal
 
Covid vaccination during pregnancy
Covid vaccination during pregnancyCovid vaccination during pregnancy
Covid vaccination during pregnancy
AnushikaKedawat
 
Covid19 and pregnancy
Covid19 and pregnancyCovid19 and pregnancy
Covid19 and pregnancy
Dr Shivani Sachdev Gour
 
Covid19 and pregnancy
Covid19 and pregnancyCovid19 and pregnancy
Covid19 and pregnancy
Shivani Sachdev
 
Hiv in pregnancy
Hiv in pregnancyHiv in pregnancy
Hiv in pregnancy
Mohamad Yaakub
 
Human immunodeficiency virus in pregnancy
Human immunodeficiency virus in pregnancyHuman immunodeficiency virus in pregnancy
Human immunodeficiency virus in pregnancy
AtlantaArchie
 

Similar to Management of covid during pregnancy (20)

CARE OF PREGNANT WOMEN WITH AYURVEDA IN COVID19
CARE OF PREGNANT WOMEN WITH AYURVEDA IN COVID19CARE OF PREGNANT WOMEN WITH AYURVEDA IN COVID19
CARE OF PREGNANT WOMEN WITH AYURVEDA IN COVID19
 
Lecture 9 Coronavirus Infection in Pregnancy
Lecture 9 Coronavirus Infection in PregnancyLecture 9 Coronavirus Infection in Pregnancy
Lecture 9 Coronavirus Infection in Pregnancy
 
CARE OF PREGNANT WOMEN DURING COVID 19 PANDEMIC
CARE OF PREGNANT WOMEN DURING COVID 19 PANDEMICCARE OF PREGNANT WOMEN DURING COVID 19 PANDEMIC
CARE OF PREGNANT WOMEN DURING COVID 19 PANDEMIC
 
COVID-19 in pregnant and postpartum women.pptx
COVID-19 in pregnant and postpartum women.pptxCOVID-19 in pregnant and postpartum women.pptx
COVID-19 in pregnant and postpartum women.pptx
 
Corona Virus Infection in Pregnancy by: Prof. Haleema A. Hashmi
Corona Virus Infection in Pregnancy by: Prof. Haleema A. HashmiCorona Virus Infection in Pregnancy by: Prof. Haleema A. Hashmi
Corona Virus Infection in Pregnancy by: Prof. Haleema A. Hashmi
 
Overview of covid 19 during pregnancy and unani medicine
Overview of covid 19 during pregnancy and unani medicineOverview of covid 19 during pregnancy and unani medicine
Overview of covid 19 during pregnancy and unani medicine
 
ytp newsletter ekika singh.pdf
ytp newsletter ekika singh.pdfytp newsletter ekika singh.pdf
ytp newsletter ekika singh.pdf
 
Restart fertility in Covid19: Indian Perspective and International Guidance
Restart fertility in Covid19: Indian Perspective and International GuidanceRestart fertility in Covid19: Indian Perspective and International Guidance
Restart fertility in Covid19: Indian Perspective and International Guidance
 
Pregnant Woman with COVID-1.pptx
Pregnant Woman with COVID-1.pptxPregnant Woman with COVID-1.pptx
Pregnant Woman with COVID-1.pptx
 
Covid 19 & and pregnancy
Covid 19 & and pregnancyCovid 19 & and pregnancy
Covid 19 & and pregnancy
 
Neha diwan ppt on covid19 in pregnancy
Neha diwan ppt on covid19 in pregnancyNeha diwan ppt on covid19 in pregnancy
Neha diwan ppt on covid19 in pregnancy
 
COVID-19 in Pregnancy Annual Perinatal2022 - Copy.pptx
COVID-19 in Pregnancy Annual Perinatal2022 - Copy.pptxCOVID-19 in Pregnancy Annual Perinatal2022 - Copy.pptx
COVID-19 in Pregnancy Annual Perinatal2022 - Copy.pptx
 
Corona and pregnancy
Corona and pregnancyCorona and pregnancy
Corona and pregnancy
 
Optimizing anc in pregnant women in sars co v-2 times
Optimizing anc in pregnant women in sars co v-2 times Optimizing anc in pregnant women in sars co v-2 times
Optimizing anc in pregnant women in sars co v-2 times
 
Pregnancy and covid 19
Pregnancy and covid 19Pregnancy and covid 19
Pregnancy and covid 19
 
Covid vaccination during pregnancy
Covid vaccination during pregnancyCovid vaccination during pregnancy
Covid vaccination during pregnancy
 
Covid19 and pregnancy
Covid19 and pregnancyCovid19 and pregnancy
Covid19 and pregnancy
 
Covid19 and pregnancy
Covid19 and pregnancyCovid19 and pregnancy
Covid19 and pregnancy
 
Hiv in pregnancy
Hiv in pregnancyHiv in pregnancy
Hiv in pregnancy
 
Human immunodeficiency virus in pregnancy
Human immunodeficiency virus in pregnancyHuman immunodeficiency virus in pregnancy
Human immunodeficiency virus in pregnancy
 

Recently uploaded

CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
phuakl
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 

Recently uploaded (20)

CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 

Management of covid during pregnancy

  • 1. EFFECTS AND MANAGEMENT OF COVID 19 ON PREGNANCY PRESENTED BY MISS DAMINEE PATEL
  • 2. CONTENT INTRODUCTION OF COVID – 19 EFFECT OF COVID -19 ON PREGNANCY MANAGEMENT OF COVID 19 ON PREGNANCY
  • 3. INTRODUCTION OF COVID 19 AGENT – Novel corona virus called covid 19 caused by SARS COV- 2 INCUBATION RANGE- 2.2 to 11.5 days
  • 4. Mode of infection • Droplet • Contact • Fomites
  • 5. Age group Any of age group Above 30 year Less common in below 10 year
  • 6. EFFECTS IN NON PREGNANT STATE Cough URT infection Fever Muscle pain Myalgia Headache Shortness of breath Loss of smell and taste Nausea vomiting and diarrhea
  • 7. Confirmatory test RT PCR It is a RNA virus and specific gene is RdRp gene.
  • 8. EFFECTS OF COVID -19 ON PREGNENCY Several research findings suggest that pregnant women at suspect or confirmed covid 19 they are more likely to need ICU as compared to non -pregnant women.
  • 9. EFFECT ON PREGNANCY The findings of many study supported that pregnant women are not greater risk of severe illness than non- pregnant women. Prone to infection Higher risk for hospitalization , ICU and ventilators.
  • 10. Continued…. Perinatal anxiety Depression Sometime Domestic violence More chance to occur pneumonia Pregnant women with heart disease are at highest risk (congenital or acquired).
  • 11. EFFECTS ON LABOUR Preterm labor. Intra uterine growth retardation Chances of infection Low birth weight baby Increase risk of transmission.
  • 12. EFFECT ON FETUS Early pregnancy - miscarriage Late pregnancy – Loss of fetus, and preterm labor. There is no evidence currently that the virus is teratogenicity. Long term data is awaited. COVID-19 infection is currently not an indication for Medical Termination of Pregnancy.
  • 13. TRANSMISSION  With regard to vertical transmission (transmission from mother to baby antenatally or intrapartum), emerging evidence now suggests that vertical transmission is probable, although the proportion of pregnancies affected and the significance to the neonate has yet to be determined.  At present, there are no recorded cases of vaginal secretions being tested positive for COVID-19.  At present, there are no recorded cases of breast milk being tested positive for COVID-19.
  • 14. DOs If a woman meets criteria for COVID- 19 testing, she should be tested. Until test results are available, she should be treated as though she has confirmed COVID-19. DONTs Do not delay obstetric management in order to test for COVID-19.
  • 15. DOs routine growth scans not for a strict guidance-based indication, routine investigations should be done regularly DONTs Elective procedures like induction of labour for indications that are not strictly necessary,
  • 16. If ultrasound equipment is used, it should be decontaminated after use. Do not expose unnecessary
  • 17. SPECIFIC OBSTETRIC MANAGEMENT Medical History For all pregnant women obtain the following information:  A detailed travel history  History of exposure to people with symptoms of COVID-19  Symptoms of COVID-19  Coming from hot spot area  Immuno compromissed conditions.
  • 18. MANAGEMENT OF COVID-19 IN PREGNANCY Women should be advised to attend routine antenatal care, unless they meet current self- isolation criteria. For women who have had symptoms, appointments can be deferred until 7 days after the start of symptoms, unless symptoms (aside from persistent cough) become severe. Fetal Kick count to be maintained.
  • 19. Continued… If needed to visit health center, should take own transport or call 108, informing the ambulance staff about her status. For women who are self-quarantined because someone in their household has possible symptoms of COVID-19, appointments should be deferred for 14 days. Any woman who has a routine appointment delayed for more than 3 weeks should be contacted. (In rural areas ANMs/ASHAs can contact by telephone/ routine household visits with PPE).
  • 20. Continued… Even if a woman has previously tested negative for COVID-19, if she presents with symptoms again, COVID-19 should be suspected. Referral to antenatal ultrasound services for foetal growth surveillance is recommended after 14 days following the resolution of acute illness.
  • 21. Continue…  Ob-gyns and other health care practitioners should follow the national protocol.  Health care practitioners should immediately notify infection control personnel at their health care facility and their local or state health department for COVID- 19.  A registry for all women admitted to with confirmed COVID-19 infection in pregnancy should be maintained. Maternal and neonatal records including outcome should be completed in detail and preserved for analysis in future.
  • 22. Continue…  Health care providers should create a plan to address the possibility of a decreased health care workforce, potential shortage of personal protective equipment, limited isolation rooms, and should maximize the use of tele health across as many aspects of prenatal care as possible.  Each facility should consider their appropriate space and staffing needs to prevent transmission of the virus that causes COVID-19.  Pregnant women should be advised to increase their social distancing to reduce the risk of infection and practice hand hygiene.
  • 23.
  • 24. Continue…  Pregnant women should be advised to increase their social distancing to reduce the risk of infection and practice hand hygiene.  Health care practitioners should promptly notify infection control personnel.  Intrapartum services should be provided in a way that is safe, with reference to minimum staffing requirements and the ability to provide emergency obstetric, anaesthetic and neonatal care where indicated.
  • 25. Continue… A single, asymptomatic birth partner should be permitted to stay with the woman, at a minimum, through pregnancy and birth. Visitors should be instructed to wear appropriate PPE, including gown, gloves, face mask, and eye protection.
  • 26. continue… Women should be met at the maternity unit entrance by staff wearing appropriate PPE and be provided with a surgical face mask. The face mask should not be removed until the woman is isolated in a suitable room. Staff providing care should take Personal Protective Equipment (PPE) precautions as per national guidance.